Azenta Inc (AZTA)
53.42
+0.85
(+1.62%)
USD |
NASDAQ |
May 03, 16:00
53.38
-0.04
(-0.07%)
After-Hours: 20:00
Azenta Accounts Receivable (Quarterly): 155.93M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 155.93M |
September 30, 2023 | 156.54M |
June 30, 2023 | 163.02M |
March 31, 2023 | 167.96M |
December 31, 2022 | 201.92M |
September 30, 2022 | 163.76M |
June 30, 2022 | 150.27M |
March 31, 2022 | 137.58M |
December 31, 2021 | 126.00M |
September 30, 2021 | 119.88M |
June 30, 2021 | 234.08M |
March 31, 2021 | 225.39M |
December 31, 2020 | 196.68M |
September 30, 2020 | 94.79M |
June 30, 2020 | 183.17M |
March 31, 2020 | 179.01M |
December 31, 2019 | 165.18M |
September 30, 2019 | 165.60M |
June 30, 2019 | 163.10M |
March 31, 2019 | 163.65M |
December 31, 2018 | 164.52M |
September 30, 2018 | 125.19M |
June 30, 2018 | 156.68M |
March 31, 2018 | 141.50M |
December 31, 2017 | 139.05M |
Date | Value |
---|---|
September 30, 2017 | 93.46M |
June 30, 2017 | 120.75M |
March 31, 2017 | 115.17M |
December 31, 2016 | 114.43M |
September 30, 2016 | 106.37M |
June 30, 2016 | 101.09M |
March 31, 2016 | 104.22M |
December 31, 2015 | 102.89M |
September 30, 2015 | 86.45M |
June 30, 2015 | 100.97M |
March 31, 2015 | 94.68M |
December 31, 2014 | 75.68M |
September 30, 2014 | 80.11M |
June 30, 2014 | 82.79M |
March 31, 2014 | 83.44M |
December 31, 2013 | 75.53M |
September 30, 2013 | 77.48M |
June 30, 2013 | 86.29M |
March 31, 2013 | 73.54M |
December 31, 2012 | 63.83M |
September 30, 2012 | 78.86M |
June 30, 2012 | 87.30M |
March 31, 2012 | 80.49M |
December 31, 2011 | 73.68M |
September 30, 2011 | 76.70M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
94.79M
Minimum
Sep 2020
234.08M
Maximum
Jun 2021
165.78M
Average
163.76M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
Bruker Corp | 475.40M |
Harvard Bioscience Inc | 16.10M |
Bionano Genomics Inc | 9.319M |
Akoya Biosciences Inc | 16.99M |
Singular Genomics Systems Inc | 0.565M |